Smoldering Multiple Myeloma Latest Advances
Find the Latest Research About Smoldering Multiple Myeloma
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 712 publications
Daratumumab or Active Monitoring for High-Risk Smoldering Multiple Myeloma.
Journal: The New England journal of medicine
Published: April 08, 2026
Early intervention for high-risk smoldering multiple myeloma (SMM).
Journal: The Cochrane database of systematic reviews
Published: March 18, 2026
FDA approves first treatment for smoldering multiple myeloma.
Journal: Cancer
Published: March 04, 2026
Corticosteroid-Resistant Secondary Immune Thrombocytopenia in Smoldering Multiple Myeloma Successfully Treated With Eltrombopag: A Case Report.
Journal: Cureus
Published: March 01, 2026
Immunoglobulin Light Chain Amyloidosis: 2026 Update on Diagnosis, Prognosis, and Treatment.
Journal: American journal of hematology
Published: January 29, 2026
Circulating Tumor Cells in Multiple Myeloma: From Peripheral Clues to Central Insights.
Journal: American journal of hematology
Published: January 28, 2026
Cystoid Macular Edema as Manifestation of Smoldering Multiple Myeloma: A Case Report.
Journal: Journal of vitreoretinal diseases
Published: January 20, 2026
Scleredema associated with smoldering myeloma: a cutaneous diagnostic clue
Journal: Semergen
Published: January 14, 2026
Recent Updates and Advancements in the Diagnosis and Management of Plasma Cell Dyscrasias.
Journal: Cureus
Published: January 10, 2026
Diagnosis, risk stratification and management of smouldering multiple myeloma.
Journal: Nature reviews. Clinical oncology
Published: January 07, 2026
Last Updated: 04/28/2026